Life sciences briefing: Monday, Feb. 4, 2008
TODAY’S HEADLINES:
PEAK Surgical takes in $21M for electrosurgical tools (release)
CellGate acquired by Australian cancer biotech ProGen for $2.5M (release)
Traversa raises $2M for RNAi-delivery technologies (release)
RemitDATA, Web-based healthcare-service co., takes in $5.5M (bizjournals.com)
Spinal-implant maker Archus Orthopedics gets $10M venture loan (release)
Promedior pulls down another $5.5M for fibrotic disease (release)
Acrongenomics takes 11 percent stake in Molecular Vision (release)
Hepatitis drug-developer Biolex withdraws IPO (IPO Home)
Employee drug screener eScreen gets Carlyle investment (release)
NovaMin raises $2.5M for dental-care products (VentureWire)
Cardious… Continue Reading
MicuRx raises $10M for new anti-infectives
MicuRx Pharmaceuticals, a Union City, Calif., developer of new anti-infective drugs, raised $10 million in a first round of funding. Morningside Group, a Hong Kong-based investment fund founded by the Chan family, provided the funding.
Founded by two former officials at Vicuron Pharmaceuticals, another maker of antimicrobial therapies that was acquired by Pfizer in 2005, MicuRx seems to be a new sort of U.S.-Chinese hybrid — one that may not even end up doing much of… Continue Reading